The National Academy of Medicine considers some pertinent ins and outs of GenAI. 

Monoclonal antibody therapies will be the first drugs permitted to take advantage of alternatives, including advanced lab simulations and artificial intelligence. A pilot framework to phase out the decades-long requirement for animal testing will be rolled out in the coming year, the FDA said.

GenAI initiatives are complex and—in some cases—costly. “As such, the main rationale for pursuing them needs to be business growth, not workforce reductions.” 

The authors of the survey report note that AI tools mentioned by respondents run the gamut from automated appointment reminders to dynamic “care gap” messaging. 

As applications of AI spread rapidly across healthcare, ambient scribes are poised to become one of the fastest technology adoptions in the history of the sector. 

Researchers have taken inspiration from starfish to design an AI-powered wearable device that delivers accurate real-time heart monitoring.

Many if not most hospitals and other provider organizations take a decided interest in what their peer institutions are doing with AI. A major motivator for the keen curiosity is gauging how well one is keeping up with the Joneses. So to speak.

Among the myriad processes to which AI could be meaningfully applied in healthcare, perhaps few are more easily overlooked than discharging patients from the hospital.